Friday, February 05, 2016 1:20:24 PM
I would recommand people pay attention to Anavex. If indeed they suceed in Alzheimer, that may be a good think for MANF. In fact ANAVEX™ PLUS is a promising, potentially novel combination drug for Alzheimer’s disease. It combines ANAVEX™ 2-73 PLUS donepezil (Aricept®) and seem to be targeting protein misfolding.
MANF seems as well to be targeting protein Misfolding as well. The application of MANF for Rare pediatric desseas anounced this morning actually goes that direction.
If ANAvex plus succeed, that means MANF has big chance with CNS(Central nervous system) deasease: Parkinson, Alzheimer, Epilepsy.
Geez, AMBS has so much potential, many people people just dont realize it
FEATURED Southern Silver Announces Updated PEA on Cerro Las Minitas: US$501M After-tax NPV5%; 21% IRR; 48 Month payback • Jun 11, 2024 5:26 AM
Swifty Global Announces South African Gambling License Approval • DRCR • Jun 10, 2024 9:15 AM
DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • SONGD • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM